by PRI | Jun 17, 2022 | Microbiome Product Developer
Cyrille Jeune COO (interim) everImmune leverages the potential of the gut microbiota for the development of therapeutic (Oncobax®) and diagnosis tools in cancer....
by PRI | Jun 17, 2022 | Microbiome Product Developer
Luc Sterkman CEO Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and...
by PRI | Jun 17, 2022 | Microbiome Product Developer
Lydia Mapstone Co-Founder & CEO BoobyBiome, a female-led UK-micro SME, is developing a rationally-designed live biotherapeutic product (LBP) tailored for babies with compromised microbiomes. Informed by rigorous scientific testing and precise characterisation of...
by PRI | Jun 17, 2022 | Microbiome Product Developer
Nail Nasir Scientific Manager Astel Medica is a fast growing belgian pharmaceutical company. Founded in 1988 with the collaboration of the University of Liège, Astel Medica is the Belgian leader in the conception and manufacturing of innovative evidence based...
